Nutex Health Inc. (NASDAQ:NUTX) Given Average Rating of “Buy” by Brokerages

Shares of Nutex Health Inc. (NASDAQ:NUTX) have been given an average recommendation of “Buy” by the four analysts that are presently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a hold recommendation, two have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1-year price objective among brokerages that have issued ratings on the stock in the last year is $300.00.

NUTX has been the subject of a number of analyst reports. Weiss Ratings raised shares of Nutex Health from a “hold (c)” rating to a “hold (c+)” rating in a research note on Tuesday, July 28th. Wall Street Zen cut shares of Nutex Health from a “strong-buy” rating to a “buy” rating in a research report on Monday, July 20th. B. Riley Financial began coverage on Nutex Health in a report on Friday, June 26th. They set a “buy” rating and a $290.00 price target for the company. Lake Street Capital reissued a “buy” rating and issued a $310.00 price objective (up from $235.00) on shares of Nutex Health in a research note on Tuesday, August 11th. Finally, Zacks Research upgraded Nutex Health from a “hold” rating to a “strong-buy” rating in a research report on Monday.

Nutex Health Stock Performance

Shares of NUTX stock opened at $195.92 on Thursday. The business’s 50 day simple moving average is $169.98 and its 200 day simple moving average is $132.58. Nutex Health has a one year low of $77.21 and a one year high of $204.00. The stock has a market capitalization of $1.34 billion, a PE ratio of 7.69 and a beta of 0.24. The company has a debt-to-equity ratio of 0.59, a current ratio of 5.00 and a quick ratio of 4.96.

Nutex Health (NASDAQ:NUTX) last released its earnings results on Thursday, August 6th. The company reported $9.38 earnings per share for the quarter, beating analysts’ consensus estimates of $4.95 by $4.43. Nutex Health had a net margin of 21.25% and a return on equity of 39.74%. The business had revenue of $210.75 million during the quarter, compared to the consensus estimate of $215.03 million. As a group, research analysts forecast that Nutex Health will post 30.11 earnings per share for the current year.

Key Headlines Impacting Nutex Health

Here are the key news stories impacting Nutex Health this week:

• Positive Sentiment: Upgraded to “strong buy”: Zacks Research upgraded Nutex Health from “hold” to “strong buy,” supporting the stock’s recent momentum. Ticker Report article
• Positive Sentiment: Positive trend and earnings signals: Zacks identified NUTX as a candidate for short-term trend investors and cited improving earnings-estimate revisions. The company’s latest reported quarter also included adjusted earnings of $9.38 per share, well above the $4.95 consensus estimate, although revenue was slightly below expectations. Zacks trend-investor article Zacks earnings-estimates article
• Positive Sentiment: Analyst upside expectations: The average Wall Street price target implies approximately 47% potential upside from the referenced price, while analysts collectively maintain a “moderate buy” recommendation. Price targets are forward-looking and may not reflect the cybersecurity risk. Zacks price-target article American Banking News analyst recommendation
• Neutral Sentiment: No Surprises Act ruling: Nutex applauded a Fifth Circuit decision rejecting portions of federal rules governing qualifying payment amount calculations. The ruling could affect healthcare reimbursement practices, but its direct financial impact on NUTX remains uncertain. PR Newswire article
• Negative Sentiment: Cybersecurity incident: Nutex reported that data was accessed and stolen during a cyberattack, with reports indicating that sensitive information may have been exposed. Potential costs, regulatory scrutiny, litigation and reputational damage create a new overhang for the shares. Yahoo Finance article SecurityWeek article

Hedge Funds Weigh In On Nutex Health

Several institutional investors have recently added to or reduced their stakes in the business. California State Teachers Retirement System increased its stake in Nutex Health by 25,615.8% in the second quarter. California State Teachers Retirement System now owns 934,768 shares of the company’s stock valued at $159,743,000 after purchasing an additional 931,133 shares in the last quarter. BlackRock Inc. bought a new position in shares of Nutex Health during the 2nd quarter worth about $69,612,000. Topline Capital Management LLC grew its stake in shares of Nutex Health by 72.0% in the 2nd quarter. Topline Capital Management LLC now owns 309,131 shares of the company’s stock valued at $38,484,000 after buying an additional 129,418 shares during the period. Winmill & CO. Inc. acquired a new stake in shares of Nutex Health in the 2nd quarter valued at about $11,168,000. Finally, Millennium Management LLC increased its position in Nutex Health by 191.1% in the 3rd quarter. Millennium Management LLC now owns 93,396 shares of the company’s stock valued at $9,650,000 after buying an additional 61,308 shares in the last quarter. 5.32% of the stock is owned by institutional investors and hedge funds.

About Nutex Health

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight?loss services and behavioral health support. By combining in?person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost?effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail?anchored centers, offering treatment for non?life?threatening injuries and illnesses, preventive screenings and basic primary care.